Search clinical trials for: Protein expression by immunohistochemistry and immunofluorescence

Total 317 results

Armando Santoro, MD

Completed

Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Italy
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

Ovarian Cancer
Lille Catholic University

Completed

Expression of DMBT1 in Colorectal Cancer Patients (DMBT1)

Colorectal Cancer | DMBT1 Protein, Human
Gynecologic Oncology Group
National Cancer Institute (NCI)

Unknown

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

Kidney Cancer | Brain and Central Nervous System Tumors
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Lymphoma
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Kidney Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Brain and Central Nervous System Tumors

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Head and Neck Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

Neuroblastoma | Neoplastic Syndrome
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

Breast Cancer | Estrogen Receptor | Her-2 | Pgr
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

Breast Cancer
AIDS Malignancy Consortium
National Cancer Institute (NCI); The Emmes Company, LLC; PTC Therapeutics

Terminated

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Kaposi's Sarcoma

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma

Sarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Young Patients With Neuroblastoma

Neuroblastoma
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Protein Expression in Samples From Young Patients With Rhabdomyosarcoma

Sarcoma
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Lymphoma
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

Head and Neck Cancer
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Colorectal Cancer
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Pancreatic Cancer

United States
Medical Research Council

Completed

DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE

Kidney Cancer

United Kingdom
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803

Prostate Cancer
Cairo University

Unknown

Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

Oral Squamous Cell Carcinoma

Egypt
Peking Union Medical College Hospital
GeneCast Biotechnology Co., Ltd.; Geneplus-Beijing Co. Ltd.; OrigiMed; YuceBio...

Recruiting

Hepatobiliary Tumors Tissue Samples Acquisition

Hepatocellular Carcinoma | Cholangiocarcinoma | Precancerous Condition | Liver Cancer | Biliary Tract Cancer | Gallbladder Cancer | Healthy, no Evidence of Disease | Benign Hepatobiliary Disease

China
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Lung Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Breast Cancer

United States
Case Comprehensive Cancer Center

Completed

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Breast Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

Neuroblastoma
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Solid Tumor

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Not yet recruiting

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Serous Adenocarcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Stage IIIc Melanoma

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Completed

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (IRB 2000-294)

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Liver Cancer
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Study of Proteins in Head and Neck Cancer Cells

Head and Neck Cancer

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Lung Cancer

United States
National Cancer Institute (NCI)

Terminated

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Intraductal Papillary Mucinous Neoplasm of the Pancreas

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

Breast Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

Neuroblastoma
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

Breast Cancer
Samsung Medical Center

Recruiting

LAG3 Expression in Triple Negative Breast Cancer

Triple Negative Breast Cancer | Immune Checkpoint Inhibitor

Korea, Republic of
Abramson Cancer Center of the University of Pennsylvania

Terminated

Brivanib Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524

Lung Cancer

United States
Sohag University

Completed

Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies

Endometrial Hyperplasia | Endometrial Adenocarcinoma

Egypt
University of Washington
National Cancer Institute (NCI)

Completed

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Assiut University

Not yet recruiting

Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia

Sickle Cell Disease, Beta Thalassemia Intermedia
Yonsei University

Unknown

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Lung Cancer

Korea, Republic of
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Sarcoma

Search clinical trials for: Protein expression by immunohistochemistry and immunofluorescence

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations